Preventive Takhzyro Reduces HAE Attacks Early in Treatment, Analysis Shows
News
Preventive treatment with Takhzyro (lanadelumab) significantly reduces the number of swelling attacks in people with hereditary angioedema (HAE), even in the early phases of treatment, a post hoc analysis from the ... Read more